Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 161
Selected: 0
NCT IDTitle
NCT03193476Registry for Patients With X-Linked Hypophosphatemia
NCT03566082Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - Europe
NCT04814680Machine-Learning Algorithm for Prediction of Blood Pressure, Glycated Haemoglobin and Estimated Glomerular Filtration Rate
NCT03120949Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
NCT04959799Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA)
NCT05066698ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects
NCT06024213A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.
NCT05782179Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants
NCT05817669A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS)
NCT06938854Investigational Study of SWM-831 to Treat Moderate and Severely Calcified Femoropopliteal Arteries
NCT05551195[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]
NCT05663515A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
NCT03553108A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.
NCT04078152Durvalumab Long-Term Safety and Efficacy Study
NCT02678572Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma
NCT03881488Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
NCT04605094Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis
NCT03254446Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension
NCT05599334A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib
NCT04422314ImmuneSense Lyme Study
NCT06712563Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
NCT02503033A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies
NCT04907968Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer
NCT04188574A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail
NCT06499571Geographic Atrophy Long-Terms Outcomes Study
NCT05776472A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT04305405PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma
NCT03970837Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
NCT04168814Nutritional Status in Locally Advanced or Metastatic Solid Cancer Patients in Spain: the NutriOncoSearch (NOS) Study
NCT04324437eRAPID: Online Symptom Reporting in Lung Cancer
NCT02374450A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
NCT03983980Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)
NCT04072835Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
NCT02654470Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)
NCT05189977A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
NCT02104817Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
NCT06073652Starter Infant Formula With Synbiotics
NCT06042049A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab
NCT04167137Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants
NCT06485674Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus
NCT04333147Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)
NCT04980638Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia
NCT03838185Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147
NCT06951867Tezspire Cardiac Events PASS
NCT03980483Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
NCT04280029SELUTION SLR™ 014 In-stent Restenosis
NCT03544281To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT05264506Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive
NCT04134728Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors
NCT04396340First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b